India to join global scheme to improve quality of drugs | Mint Primer | Mint

This video explores the reasons behind India's decision to join PIC/S and its potential impact on the Indian pharmaceutical market. The UAE and other advanced economies often reference prices in developed markets, which pose barriers for affordable Indian drugs, despite their superior quality. Talks are underway to address pricing norms and facilitate Indian generic drug and vaccine exports. The absence of India and China from PIC/S has skewed the price mechanism towards higher prices, hindering Indian exporters of affordable medicines